AU Stock MarketDetailed Quotes
BDX BCAL Diagnostics Ltd
- 0.105
- 0.0000.00%
20min DelayTrading Nov 5 12:47 AET
37.66MMarket Cap-4038P/E (Static)
0.105High0.100Low1.05MVolume0.100Open0.105Pre Close107.19KTurnover0.18552wk High0.50%Turnover Ratio358.66MShares0.08552wk Low-0.026EPS TTM21.93MFloat Cap0.275Historical HighLossP/E (Static)208.81MShs Float0.051Historical Low-0.026EPS LYR4.76%Amplitude--Dividend TTM4.38P/B1Lot Size--Div YieldTTM
About BCAL Diagnostics Ltd Company
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.
Company Profile
SymbolBDX
Company NameBCAL Diagnostics Ltd
Founded2010
MarketASX
Fiscal Year Ends06-30
AddressQueen Victoria Building GPO Box Q128
CitySydney
CountryAustralia
Zip Code1230
Share RegistryAUTOMIC REGISTRY SERVICES
Level 1, 45 Clarence Street, SYDNEY, NSW, AUSTRALIA, 2000
13 25 83
Company Executives
- Name
- Position
- Salary
- Jayne Andrea Shaw
- Executive Chairman,Executive Director
- --
- Jonathan Alfred Grey Trollip
- Non-Executive Director
- --
- Ronald (Ron) Anthony Phillips
- Non-Executive Director
- --
- Merilyn Joy Sleigh
- Non-Executive Director
- --
- Mark Douglas Irving Burrows
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data